{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:35:58Z","timestamp":1791462958637,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571169"],"award-info":[{"award-number":["81571169"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701339"],"award-info":[{"award-number":["81701339"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31871171"],"award-info":[{"award-number":["31871171"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.neuropharm.2018.11.022","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T01:25:57Z","timestamp":1543281957000},"page":"149-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Ketamine may exert antidepressant effects via suppressing NLRP3 inflammasome to upregulate AMPA receptors"],"prefix":"10.1016","volume":"146","author":[{"given":"Jia-Mei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jun","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Lei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.11.022_bib1","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1001\/jama.2017.12975","article-title":"Ketamine minus the trip: new hope for treatment-resistant depression","volume":"318","author":"Abbasi","year":"2017","journal-title":"Jama"},{"key":"10.1016\/j.neuropharm.2018.11.022_bib2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pharmthera.2018.05.010","article-title":"The neurobiology of depression, ketamine and rapid-acting antidepressants: is it glutamate inhibition or activation?","volume":"190","author":"Abdallah","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2018.11.022_bib5","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1213\/ANE.0b013e3182662e30","article-title":"Does intraoperative ketamine attenuate inflammatory reactivity following surgery? A systematic review and meta-analysis","volume":"115","author":"Dale","year":"2012","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2018.11.022_bib7","doi-asserted-by":"crossref","first-page":"772","DOI":"10.7326\/0003-4819-155-11-201112060-00009","article-title":"Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis","volume":"155","author":"Gartlehner","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.neuropharm.2018.11.022_bib9","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.pnpbp.2010.06.013","article-title":"The role of glutamate on the action of antidepressants","volume":"35","author":"Hashimoto","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.11.022_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2011.05.035","article-title":"Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression","volume":"224","author":"Koike","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.11.022_bib12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/mp.2017.76","article-title":"Gene deficiency and pharmacological inhibition of caspase-1 confers resilience to chronic social defeat stress via regulating the stability of surface AMPARs","volume":"23","author":"Li","year":"2018","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.11.022_bib13","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1471-4159.2006.03800.x","article-title":"Evidence that caspase-1 is a negative regulator of AMPA receptor-mediated long-term potentiation at hippocampal synapses","volume":"97","author":"Lu","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2018.11.022_bib14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.11.022_bib16","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.neuropharm.2018.11.022_bib17","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03581","article-title":"GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine","volume":"3","author":"Miller","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.neuropharm.2018.11.022_bib18","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(96)07492-2","article-title":"Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study","volume":"349","author":"Murray","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2018.11.022_bib19","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1176\/appi.ajp.2015.15040465","article-title":"Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression","volume":"172","author":"Newport","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.11.022_bib20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/bmb\/lds004","article-title":"The neurobiology of depression","volume":"101","author":"Palazidou","year":"2012","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.neuropharm.2018.11.022_bib21","article-title":"Lipopolysaccharide-induced depressive-like behavior is associated with alpha(1)-adrenoceptor dependent downregulation of the membrane GluR1 subunit in the mouse medial prefrontal cortex and ventral tegmental area","volume":"18","author":"Sekio","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.11.022_bib22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2215-0366(17)30272-9","article-title":"Side-effects associated with ketamine use in depression: a systematic review","volume":"5","author":"Short","year":"2018","journal-title":"Lancet Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.11.022_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12964-014-0075-5","article-title":"NMDA-receptor antagonists block B-cell function but foster IL-10 production in BCR\/CD40-activated B cells","volume":"12","author":"Simma","year":"2014","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.neuropharm.2018.11.022_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2017.01.018","article-title":"NLRP3 gene knockout blocks NF-\u03baB and MAPK signaling pathway in CUMS-induced depression mouse model","volume":"322","author":"Su","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.11.022_bib26","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1248\/bpb.b17-00131","article-title":"Ketamine alleviates depressive-like behaviors via down-regulating inflammatory cytokines induced by chronic restraint stress in mice","volume":"40","author":"Tan","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.neuropharm.2018.11.022_bib27","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/jnr.21325","article-title":"Neuroinflammation and regulation of glial glutamate uptake in neurological disorders","volume":"85","author":"Tilleux","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2018.11.022_bib29","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.3892\/etm.2013.930","article-title":"Ketamine exerts antidepressant effects and reduces IL-1beta and IL-6 levels in rat prefrontal cortex and hippocampus","volume":"5","author":"Yang","year":"2013","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.neuropharm.2018.11.022_bib30","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3892\/mmr.2013.1600","article-title":"Effects of ketamine on lipopolysaccharide-induced depressive-like behavior and the expression of inflammatory cytokines in the rat prefrontal cortex","volume":"8","author":"Yang","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.neuropharm.2018.11.022_bib31","doi-asserted-by":"crossref","first-page":"e632","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.11.022_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jneuroim.2015.03.012","article-title":"Immunomodulatory activity of ketamine in human astroglial A172 cells: possible relevance to its rapid antidepressant activity","volume":"282","author":"Yuhas","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2018.11.022_bib33","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.11.022_bib34","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1007\/s00213-015-4062-3","article-title":"Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression","volume":"232","author":"Zhang","year":"2015","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.11.022_bib35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jnutbio.2016.10.004","article-title":"Prophylactic effects of sulforaphane on depression-like behavior and dendritic changes in mice after inflammation","volume":"39","author":"Zhang","year":"2017","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.neuropharm.2018.11.022_bib36","doi-asserted-by":"crossref","first-page":"ra123","DOI":"10.1126\/scisignal.aai7884","article-title":"Essential roles of AMPA receptor GluA1 phosphorylation and presynaptic HCN channels in fast-acting antidepressant responses of ketamine","volume":"9","author":"Zhang","year":"2016","journal-title":"Sci. Signal."},{"key":"10.1016\/j.neuropharm.2018.11.022_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv006","article-title":"NLRP3 inflammasome mediates chronic mild stress-induced depression in mice via neuroinflammation","volume":"18","author":"Zhang","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.11.022_bib38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/cns.12170","article-title":"Involvement of inflammasome activation in lipopolysaccharide-induced mice depressive-like behaviors","volume":"20","author":"Zhang","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2018.11.022_bib39","doi-asserted-by":"crossref","first-page":"23742","DOI":"10.1038\/srep23742","article-title":"Effects of hydrogen-rich water on depressive-like behavior in mice","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818306841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818306841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:53:20Z","timestamp":1758437600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818306841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":31,"alternative-id":["S0028390818306841"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.11.022","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ketamine may exert antidepressant effects via suppressing NLRP3 inflammasome to upregulate AMPA receptors","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}